You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

Gastroenterology

Esophageal Dilation Does Not Impact Underlying Inflammation in EoE

Dr. Evan Dellon discusses why esophageal dilation improves symptoms but does not address the underlying histology or disease activity in EoE.

MD, MPH

Evan Dellon

1 minutes

Learning objectives

Recognize that esophageal dilation can improve symptoms in EoE patients with strictures but it does not impact underlying, persistent type 2 inflammation

Description

Join Evan Dellon, MD, MPH, as he discusses the mechanisms by which esophageal dilation can improve symptoms but does not address the underlying histology or disease activity in EoE.

About this expert

Gastroenterology

Evan Dellon

MD, MPH

Professor of Medicine and Adjunct Professor of Epidemiology | University of North Carolina School of Medicine, Chapel Hill, United States

See author’s profile

Related resources

Gastroenterology

4 min

expert video

Overview of EoE Pathophysiology and the Impact on Patient Burden

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

Gastroenterology

17 min

Podcast

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

ADVENT On Air | More Than Just Difficulty Swallowing: EoE Burden and Diagnosis

Gastroenterology

12 min

Podcast

Assessing EoE: Using Endoscopic Features to Assess Disease Status

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region

Esophageal Dilation Does Not Impact Underlying Inflammation in EoE

Learning objectives

Description

About this expert

Evan Dellon

Related resources

Overview of EoE Pathophysiology and the Impact on Patient Burden

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

ADVENT On Air | More Than Just Difficulty Swallowing: EoE Burden and Diagnosis

Adaptive Behaviors in EoE Infographic

Pediatric EoE Disease Burden Infographic

EoE Burden and Pathophysiology of Type 2 Inflammation

2021: EoE Year in Review

2022: EoE Year in Review

Assessing EoE: Assessing Histologic Features in EoE

Assessing EoE: Measuring Quality of Life in Patients With EoE

Complex EoE Pathophysiology Beyond Esophageal Eosinophilia

Cumulative Exposure to Corticosteroids in Type 2 Inflammatory Diseases

EoE: A Chronic, Progressive, Type 2 Inflammatory Disease Infographic

Eosinophilic Esophagitis (EoE) Interactive Patient Case

Esophageal Dilation Does Not Impact Underlying Inflammation in EoE

Food Bolus Impaction: An Opportunity to Diagnose EoE

Gap in Care Leads to Progression of Fibrosis in EoE

Impact of Delayed EoE Diagnosis on Disease Progression and QoL

Importance of Assessing Key Disease Domains in EoE Infographic

Importance of Assessing Multiple Disease Domains in EoE

Importance of Early Diagnosis of Pediatric EoE

Importance of Monitoring and Maintenance in EoE

In It Together: An Interdisciplinary Approach to EoE Care

Interdisciplinary Care for EoE: Experts Offer Food for Thought

Interplay of Barrier Dysfunction and Type 2 Inflammation in EoE

It Takes a Village: Patient-Centered Care in Pediatric EoE

Managing the Risk of Fibrostenosis in EoE

More Than Eosinophils: A Closer Look at the Pathophysiology of EoE

Multifaceted Burden of Pediatric EoE

Patient Burden in Eosinophilic Esophagitis

Patient Case - The Value of a Complete Pathology Report in EoE

Patient Case - The Value of an Interdisciplinary Team in EoE Patient Care

Scientific Advances in EoE and Impact on Clinical Practice

The Need for Maintenance Therapy in EoE

Keeping an Eye on Pediatric EoE

2021: EoE Year in Review - Pathophysiology

Piecing Together the Puzzle in Patients With EoE

Assessing EoE: Assessing Symptoms in Patients With EoE

UEGW 2024 | Something to Chew On: Exploring the Management of EoE

UEGW 2024 | WHY Is Long-Term Management of EoE Important?

UEGW 2024 | WHAT Can Be Used to Monitor Treatment Response in EoE and WHEN?

Eosinophilic Esophagitis (EoE) Pediatric Interactive Patient Case

Assessing EoE: Monitoring Patients With EoE in Clinical Practice

Assessing EoE: Using Endoscopic Features to Assess Disease Status